Latest News
Read more news
-
PathWest Star of the Future - Sam Neeling 27 April 2022 Samuel Neeling, Medical Scientist, Immunology, is one of the successful recipients of the PathWestEarly Career Research Awards that were awarded in February 2022. Sam's research project will be investigating “In-vitro measurement of the neutralising effect of anti-GMCSF or anti-IFN-γ antibodies on STAT phosphorylation using patient serum and donor peripheral blood mononuclear cells”. Sam explains his project as, “Cytokines and Signal Transducer and Activator of Transcription (STAT) proteins are important for mediating cellular immune function. GM-CSF and Interferon γ (IFN- γ) are crucial cytokines that act on monocytes via the JAK/STAT pathway. Anti- IFN-γ antibodies are a known cause of adult onset immunodeficiency and anti-GM-CSF antibodies are associated with Pulmonary Alveolar Proteinosis (PAP). Autoantibodies against these cytokines have bee... -
Easter and ANZAC Day public holidays 12 April 2022 Our PathWest collection centres are closed on Friday 15 April and Monday 18 April, the Easter public holidays. For those centres who usually open on Saturdays we are open on Saturday 16 April and our regular opening hours resume on Tuesday 19 April. On ANZAC Day on Monday 25 April our centres will be closed, with regularopening hours resumingon Tuesday 26 April. COVID testing continues over weekends and public holidays however there is some adjustmentto the COVID testing hours over the Easter weekend as indicated below. Friday 15th April Saturday 16th April Sunday 17th April Monday 18th April 08:00 – 16:00 08:00 – 16:0... -
PathWest Star of the Future - Daniel White 04 April 2022 Daniel White, Medical Scientist, Biochemistry, is one of the successful recipients of the Chief Pathologist Early Career Research Awards that were awarded at the PathWestConsultant Pathologists' Symposium inFebruary 2022. Daniel's research project will be investigating “Utilising Phosphatidylethanol (PEth) at patient triage will provide superior rate of detection of alcohol-induced injury than direct alcohol measurements alone”. Daniel explains his project as, “Detecting dangerous alcohol consumption can be quite difficult because current laboratory testing methods can only detect heavy drinking in the past 12-18 or so hours, or after damage has already been inflicted on the body from alcohol exposure. Clinicians also rely on patient testimony to establish the amount and duration of alcohol consumption, which can be unreliable. In the Emergency Department in particular,... -
Your chance to be a part of important COVID-19 Research 24 March 2022 Have you and/or your child tested positive to COVID-19 recently and wish to participate in a COVID-19 Immunity biobank study? Researchers at PathWest and WA Health are providing adults and children who have tested positive to COVID-19 with the opportunity to participate in innovative research. This study will help us understand; · COVID-19 immunity, · how immunity to the SARS-CoV-2 virus develops, · how long it lasts, · and to develop diagnostic laboratory tests to demonstrate whether someone is immune to COVID-19. If you and/or your child would like to take part, you will be asked to provide blood and saliva samples at one of our participating sites over a period of two years. To register your interest, please visit https://redcap.link/WACICBiobank More information on the Western Australian COVID-19 Immunity Collaborative (WACIC) Biobank study is ... -
FISH testing - a PathWest collaboration 17 March 2022 Diagnostic Genomics at PathWest recently featured in relation to the ongoing collaboration with Genetic Services of WA in the context of diagnosis of rare diseases. Another important collaboration within PathWest is an inter-departmental one with Diagnostic Genomics (DG) and Anatomical Pathology (AP) in the area of FISH testing on oncology samples. FISH (Fluorescence In Situ Hybridisation) is a technique that uses DNA probes, which have different coloured fluorescent molecules attached to them, to target specific areas of the genome. FISH tests are routinely used in the diagnosis, subclassification and prognostication of a variety of tumours, including; lymphomas soft tissue malignancies lung cancers mesotheliomas brain tumours salivary gland cancers melanomas tumours of childhood, and more. Confirmation of certain abnormalities e.g. ALK, ROS1 and NTRK...
Last Updated:
20/05/2025